17 okt: Danmarks Skibskredit A/S - optagelse til handel og officiel noter..
17 okt: Gate Ventures PLC – optagelse til handel af nye aktier
17-10-2017 10:36:34

Transactions in relation to share buyback program

Relateret indhold
17 nov - 
GN: Franske Exane øger shortposition
16 nov - 
Torsdagens aktier: Genmab og GN forrest i bedste dag si..
16 nov - 
Torsdagens aktier: Genmab og GN førte an i bedste C20-d..
Relateret debat
02 nov - 
Er der nogen der ved, om det er RTX teknologi, der brug..
02 nov - 
Jeg vil også have en gratis kontantstrøm.
02 nov - 
Delårsrapport Q3 2017: Fortsat solid organisk omsætning..

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on market abuse and the delegated regulation (EU) no. 2016/1052 of 8 March 2016, also referred to as the Safe Harbor rules (company announcement no. 20 of May 4, 2017).

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program. Under the share buyback program, which is running from May 4, 2017 and ending no later than March 12, 2018, GN intends to buy back shares for an amount of up to DKK 1,000 million.

The following transactions have been made under the program in the period October 10, 2017 – October 16, 2017: 

 

No. of shares

Average purchase price, DKK

Transaction Value, DKK

October 10, 2017

10,000

210.87

2,108,724

October 11, 2017

10,000

210.22

2,102,214

October 12, 2017

10,000

208.32

2,083,219

October 13, 2017

10,000

206.90

2,068,984

October 16, 2017

10,000

208.07

2,080,669

Accumulated under the program

2,280,844

200.07

456,338,116

Following the above transactions GN owns a total of 8,213,060 own shares corresponding to 5.6% of the company’s total share capital. Every Tuesday, GN will announce the number and value of repurchased shares in company announcements to Nasdaq Copenhagen.

For further information, please contact:

Investors and analysts

Peter Justesen

VP – Investor Relations & Treasury

Tel: +45 45 75 87 16

Press and the media

Lars Otto Andersen-Lange

Group Media Manager

Tel: +45 45 75 02 55

About GN Group

GN Group is a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. We transform lives through the power of sound: Smart Hearing aids that enhance the lives of people with hearing loss; integrated headset and communications solutions that assist professionals in all types of businesses to be more productive; wireless headsets and earbuds designed to support any lifestyle – from sports enthusiasts to commuters and office workers.

With world leading expertise in the human ear, sound, wireless technology and miniaturization, GN’s innovative and intelligent audio solutions are marketed by the brands Jabra, ReSound, Beltone and Interton in 100 countries across the world. Founded in 1869, the GN Group today has more than 5,000 employees and is listed on Nasdaq Copenhagen (GN.CO).

Visit our homepage GN.com - and connect with us on LinkedIn, Facebook and Twitter.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Vindindustriens reaktion på prispres vil være i fokus på konference

21-11-2017 15:30:19
Vindmølleindustriens reaktion på prispresset afledt af overgangen til auktionsbaserede systemer vil være i fokus, når den europæiske vindmølleforening, Windeurope, 28-30. november holder konference i Amsterdam.Det vurderer Jacob Pedersen, aktieanalysechef i Sydbank, over for Ritzau Finans.- Prisudviklingen og det pres, det kommer til at skabe hele vejen ned i værdikæden i forhold til at opføre vin..

Novo/CEO: Effekt skal skærme tabletmiddel mod prispres

21-11-2017 12:24:46
Det handler om effekt, når Novo skal sikre, at selskabet ikke fanges i det prispres, der har ramt markedet for diabetesmedicin i tabletform.Det siger administrerende direktør i Novo Nordisk Lars Fruergaard Jørgensen tirsdag på selskabets kapitalmarkedsdag.Novo er i færd med at udvikle diabetes 2-midlet Semaglutid i tabletform og står dermed på spring til et kæmpe marked for tabletbehandling af typ..

Aktier/middag: C20 falder trods fremgang til Mærsk og Novo

21-11-2017 11:16:39
Størstedelen af de danske eliteaktier er i bakgear tirsdag formiddag, hvor C20 Cap-indekset falder med 0,1 pct. til 1123,30.Generelt er udsvingene ikke ret store, efterhånden som regnskabssæsonen er ved at nå sin afslutning.I stedet fokuserer investorerne blandt andet på udfaldet af forhandlingerne om den amerikanske skatteaftale, hvor Senatet snart skal stemme sit bud igennem, hvorefter der skal ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo/CEO: Vi er tilbage på sporet
2
Pandora: Amerikansk forhandler må nedjustere efter svagt kvartal - NY
3
Novo-chef er bekymret for fremtiden grundet diabetesepidemi - citat
4
Novo planlægger fase 3-udviklingsprogram med subkutan Semaglutid - NY
5
Vindindustriens reaktion på prispres vil være i fokus på konference

Relaterede aktiekurser

GN Store Nord A/S 213,10 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. november 2017 06:09:57
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171108.1 - EUROWEB4 - 2017-11-22 06:09:57 - 2017-11-22 06:09:57 - 1 - Website: OKAY